Mazokalim

Cell Line Description Ma-Mel-39a (ESTDAB-172) was established from the cutaneous/subcutaneous metastasis in a 57 year-old female patient with metastatic melanoma (superficial spreading melanoma stage IV). The Ma-Mel-39a cell line is one of more

Cell Line Description Ma-Mel-54a (ESTDAB-174) was established from the lymph node metastasis in a 41 year-old female patient with metastatic melanoma (superficial spreading melanoma stage IV). The Ma-Mel-54a cell line is one of more than 170

A cell-permeable pentanylbenzamide compound that acts as an allosteric, reversible, and selective inhibitor of the collgenolytic activity of MT1-MMP. Does not affect the catalytic activity of cellular MT-1-MMP thus allows it to retain its ability